According to Keros Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 13787. At the end of 2023 the company had a P/S ratio of > 1000.
Year | P/S ratio | Change |
---|---|---|
2023 | > 1000 | |
2022 | N/A | -100% |
2021 | 68.1 | |
2020 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |